Pharmacist’s Letter | Clinical Updates, CE & Recommendations You Can Trust

September 2026 Issue

Know What’s New With Flu Vaccines for 2026-2027

Patients will look to you for guidance on 2026-2027 flu vaccines…

Resources

Chart: Flu Vaccines for 2026-27 (United States)
FAQ: Communicating About Flu Vaccination
Algorithm: Pneumococcal Vaccination in Adults
Chart: RSV Vaccines
FAQ: Shingles Vaccine (Shingrix) FAQs
FAQ: Tetanus Prevention and Vaccination

COVID-19 Prevention: Vaccines and Post-Exposure Prophylaxis

Questions will come up about 2026-2027 COVID-19 vaccines and the first ORAL med for post-exposure prophylaxis, ensitrelvir (Xocova)…

Prevent Mishaps Involving Unusual Dosing Schedules

You’ll hear buzz about med errors related to unique dosing schedules (weekly, monthly, etc)…

Enlicitide: The First ORAL PCSK9 Inhibitor for Cholesterol

You’ll hear that enlicitide (Lipfendra) is a game changer for managing high cholesterol...

GO TO FULL ISSUE

CE & Training

Healthcare image with scattered pills on blue surface representing wellness and lifestyle.

INTERACTIVE SELF-STUDY CE: Comprehensive Diabetes Care: Navigating Complications and Acute Scenarios

CE IN THE LETTER: Pharmacist's Letter September 2026

LIVE CE: Pharmacy Essential Updates September 2026

PODCAST CE: Medication Talk - Estimating Kidney Function in Chronic Kidney Disease

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Stepwise Treatment of Asthma (<12 years of age)

Free CE for Pharmacists

Pharmacist's Letter offers ACPE-accredited CE at no charge to help pharmacists meet license renewal requirements. Claim your free CE now:

Group Purchases & Pricing

Pharmacist’s Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information